Asia-Pacific Interventional Cardiology Procedures Outlook to 2021
GlobalData’s new report, Asia-Pacific Interventional Cardiology Procedures Outlook to 2021, provides key procedures data on the Asia-Pacific Interventional Cardiology Procedures. The report provides procedure volumes within market segments - Angiography Procedures, Balloon Angioplasty Procedures, Coronary Stenting Procedures, PTCA Drug Eluting Balloon (DEB) Angioplasty Procedures and Percutaneous Coronary Intervention (PCI) Procedures.
The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.
Asia-Pacific Interventional Cardiology Procedures volumes by segments - Angiography Procedures, Balloon Angioplasty Procedures, Coronary Stenting Procedures, PTCA Drug Eluting Balloon (DEB) Angioplasty Procedures and Percutaneous Coronary Intervention (PCI) Procedures.
Projections for each of the market segments. Data is provided from 2007 to 2014 and forecast to 2021.
Reasons to buy
Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
Develop market-entry and market expansion strategies.